Schmidt, J., Abel, U., Debus, J., Harig, S., Hoffmann, K., Herrmann, T., . . . Büchler, M. W. (2012). Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. Journal of clinical oncology, 30(33), . https://doi.org/10.1200/JCO.2011.38.2960
Chicago-Zitierstil (17. Ausg.)Schmidt, Jan, Ulrich Abel, Jürgen Debus, Sabine Harig, Katrin Hoffmann, Thomas Herrmann, Dirk Jäger, und Markus W. Büchler. "Open-label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients with Resected Pancreatic Adenocarcinoma." Journal of Clinical Oncology 30, no. 33 (2012). https://doi.org/10.1200/JCO.2011.38.2960.
MLA-Zitierstil (9. Ausg.)Schmidt, Jan, et al. "Open-label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients with Resected Pancreatic Adenocarcinoma." Journal of Clinical Oncology, vol. 30, no. 33, 2012, https://doi.org/10.1200/JCO.2011.38.2960.